Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 7:17 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1009–1032 of 46,446 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Intervention/procedure Clear all

Conditions: Traumatic Brain Injury
Interventions: tDCS, [11C] Raclopride; Device · Drug
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 60 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2024
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Obesity
Interventions: Alternate Day Intermittent Energy Restriction, Reduced Calorie Diet; Other
Lead sponsor: Texas Tech University; Other
Eligibility: 18 Years to 25 Years
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 2
States / cities: Lubbock, Texas

Conditions: Low Back Pain
Interventions: HVLA-SM, LVVA-SM, Sham Intervention; Other
Lead sponsor: Palmer College of Chiropractic; Other
Eligibility: 21 Years to 65 Years
Enrollment: 221 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Davenport, Iowa

Conditions: Anxiety Disorders, Psychotic Disorders, Depressive Disorder, Psychosocial Functioning
Interventions: Resilience Training for Teens; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 14 Years to 19 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Healthy Participants
Interventions: Eptinezumab Mammalian Cell Line, Eptinezumab Yeast Cell Line; Drug
Lead sponsor: H. Lundbeck A/S; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 84 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: Daytona Beach, Florida • Madison, Wisconsin

Conditions: Alzheimer Disease, Alzheimer Disease, Late Onset, Memory Loss, Patient Education as Topic
Interventions: Web-based education; Behavioral
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 14 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Sarcoma
Interventions: dactinomycin, cyclophosphamide, etoposide, ifosfamide, vincristine sulfate, Conventional Surgery, MESNA (mercaptoethane sulfonate), Filgrastim; Biological · Drug · Procedure
Lead sponsor: Children's Oncology Group; Network
Eligibility: Up to 2 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 64
States / cities: Phoenix, Arizona • Little Rock, Arkansas • Downey, California + 57 more

Conditions: Obesity
Interventions: Bariatric surgery; Procedure
Lead sponsor: Ascension St. Vincent Carmel Hospital; Other
Eligibility: 18 Years and older
Enrollment: 414 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Carmel, Indiana

Conditions: Depressive Disorder, Major
Interventions: Cognitive behavioral therapy (CBT) and medication, Psychoeducation and medication; Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: HIV Infection
Interventions: Blood draw; Procedure
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2011
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Human Immunodeficiency Virus
Interventions: Project ADHERE, MACE; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: DKA
Interventions: Insulin Glargine; Drug
Lead sponsor: HealthPartners Institute; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Conditions: Prostate Cancer
Interventions: Pressure applied during RARP; Procedure
Lead sponsor: Metro Health, Michigan; Other
Eligibility: 40 Years and older · Male only
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Wyoming, Michigan

Conditions: Conductive Hearing Loss, Conductive and Sensori-neural Hearing Loss in the Same Ear, Unilateral, Profound Sensori-neural Hearing Loss
Interventions: Wide diameter bone anchored implant; Device
Lead sponsor: Oticon Medical; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 2
States / cities: Sarasota, Florida • Farmington Hills, Michigan

Conditions: Venous Thromboembolism, Deep Venous Thrombosis, Post-Thrombotic Syndrome
Interventions: ClotTriever System, Commercially available/market approved anticoagulation medication including but not limited to: Heparin Sodium, Coumadin, Rivaroxaban, Apixaban, etc.; Device · Drug
Lead sponsor: Inari Medical; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 48
States / cities: Scottsdale, Arizona • Tucson, Arizona • Orange, California + 43 more

Conditions: Berylliosis, Beryllium Disease
Interventions: Infliximab, Placebo; Drug · Other
Lead sponsor: Maier, Lisa, M.D.; Individual
Eligibility: 18 Years to 80 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Obesity, Cardiovascular Diseases, Metabolic Disease, High-intensity Interval Training
Interventions: high-intensity interval training intervention; Other
Lead sponsor: Syracuse University; Other
Eligibility: 18 Years to 25 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: Opioid Use Disorder
Interventions: Computerized Anxiety Sensitivity Treatment; Behavioral
Lead sponsor: Southeast Louisiana Veterans Health Care System; Federal
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Psychotic Disorder
Interventions: Mobile After-Care Support (MACS) app, Mobile app attention control; Behavioral
Lead sponsor: Butler Hospital; Other
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Bipolar Disorder, Major Depressive Disorder
Interventions: Enhanced Care, Family-Focused Treatment; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 9 Years to 17 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2020
U.S. locations: 3
States / cities: Los Angeles, California • Stanford, California • Boulder, Colorado

Conditions: Coronary Artery Disease
Interventions: Ticagrelor 90 mg, Prasugrel 10 mg; Drug
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 75 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Interventions: Bevacizumab, Biospecimen Collection, Carboplatin, Computed Tomography, Magnetic Resonance Imaging, Paclitaxel, Pembrolizumab; Biological · Procedure · Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older · Female only
Enrollment: 255 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 309
States / cities: Birmingham, Alabama • Anchorage, Alaska • Phoenix, Arizona + 230 more

Conditions: Coronary Artery Disease, Vascularization
Interventions: Acceptance and commitment therapy; Behavioral
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Left Ventricular Dysfunction
Interventions: Adult stem cells, Placebo; Biological
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 21 Years and older
Enrollment: 87 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 5
States / cities: Gainesville, Florida • Minneapolis, Minnesota • Cleveland, Ohio + 2 more

Search by objective public record fields.

Neural Basis of Decision-Making Deficits in Traumatic Brain Injury

Effect of a 4-week Alternate Day Intermittent Energy Restriction Intervention vs Reduced

Effect of Spinal Manipulation on Sensorimotor Functions in Back Pain Patients

Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness

A Study in Healthy Adults Investigating Eptinezumab Produced by 2 Different Manufacturing Cell Lines

Effectiveness of Alzheimer's Universe (Www.AlzU.Org) on Knowledge and Behavior

Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma

The Long Term Impact of Bariatric Surgery on Quality of Life

Cognitive Therapy to Sustain the Antidepressant Effects of Intravenous Ketamine in Treatment-resistant Depression

Differences in Blood Levels of Nevirapine in HIV-infected Patients in Uganda and the United States

Contextualizing & Responding to HIV Risk Behaviors

Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis

The Impact of Low Pressure Pneumo in RARP II

Wide Diameter Bone Anchored Implant Study

DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis

Beryllium Infliximab Study: Clinical Interventional Trial

HIIT Effects on Cardiometabolic Health

Computerized Anxiety Sensitivity Treatment for Opioid Use Disorders

Mobile After-Care Support App: Pilot RCT

Early Intervention for Youth at Risk for Bipolar Disorder

Switching From Dual Antiplatelet Therapy to Monotherapy With Potent P2Y12 Inhibitors

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Acceptance and Commitment Therapy for Patients Undergoing Coronary Artery Bypass Graft Surgery

Use of Adult Autologous Stem Cells in Treating People 2 to 3 Weeks After Having a Heart Attack (The Late TIME Study)